Vulnerability of drug-resistant EML4-ALK rearranged lung cancer to transcriptional inhibition.
Paliouras AR, Buzzetti M, Shi L, Donaldson IJ, Magee P, Sahoo S, Leong HS, Fassan M, Carter M, Di Leva G, Krebs MG, Blackhall F, Lovly CM, Garofalo M.
Paliouras AR, et al. Among authors: blackhall f.
EMBO Mol Med. 2020 Jul 7;12(7):e11099. doi: 10.15252/emmm.201911099. Epub 2020 Jun 17.
EMBO Mol Med. 2020.
PMID: 32558295
Free PMC article.